Free tool
Oncology stocks
We cover 183 companies grouped under the Oncology theme. The median market value in the group is $132.77M. Across the group, the median move over the past trading day is +1.58%. 51% of the 179 with a 200-day average trade above it. Price change over the past year runs from −82.7% to +210.9% across the middle 80 percent of the group, with a median of +3.9%. Across the group, 1 company currently carries a tier A volume signal.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
183 of 319 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| NUVL | Nuvalent Inc | $123.96 | 0.00% | +22.93% | +67.40% |
| CGON | CG Oncology, Inc. | $78.95 | +7.39% | +88.92% | +210.58% |
| LNTH | Lantheus Holdings, Inc. | $100.87 | −6.63% | +49.95% | +79.61% |
| COGT | Cogent Biosciences, Inc. | $36.80 | −9.00% | +5.93% | +212.13% |
| ERAS | Erasca, Inc. | $17.76 | −5.88% | +394.71% | +1016.98% |
| RLAY | Relay Therapeutics, Inc. | $20.57 | +10.35% | +151.47% | +486.04% |
| ELVN | Enliven Therapeutics, Inc. | $61.01 | +15.69% | +292.60% | +205.89% |
| CELC | Celcuity Inc. | $92.27 | +12.16% | −8.23% | +87.35% |
| TNGX | Tango Therapeutics, Inc. | $24.51 | −8.27% | +174.47% | +264.73% |
| IDYA | IDEAYA Biosciences, Inc. | $42.48 | +15.53% | +25.49% | +71.91% |
| RCUS | Arcus Biosciences, Inc. | $31.57 | +13.40% | +35.55% | +211.03% |
| TLX | Telix Pharmaceuticals Limited | $11.68 | +17.03% | +53.28% | −4.26% |
| IMNM | Immunome, Inc. | $29.39 | +30.14% | +41.14% | +196.22% |
| ZLAB | Zai Lab Limited | $26.17 | +40.40% | +51.01% | −23.10% |
| SLS | SELLAS Life Sciences Group, Inc. | $14.09 | +29.98% | +223.91% | +637.70% |
| NRIX | Nurix Therapeutics, Inc. | $26.95 | +15.02% | +49.22% | +178.70% |
| NUVB | Nuvation Bio Inc. | $7.10 | +6.61% | −17.25% | +146.53% |
| URGN | UroGen Pharma Ltd. | $46.36 | +11.82% | +104.14% | +150.59% |
| XNCR | Xencor, Inc. Common Stock | $29.30 | +47.53% | +96.38% | +265.79% |
| HCM | HUTCHMED (China) Limited | $12.26 | +10.25% | −10.18% | −23.04% |
| NBTX | Nanobiotix S.A. | $41.51 | +3.31% | +87.57% | +321.42% |
| NVCR | NovoCure Limited | $17.62 | +3.46% | +34.30% | +50.60% |
| ZYME | Zymeworks Inc. | $27.47 | +19.43% | +3.19% | +88.54% |
| IMCR | Immunocore Holdings plc | $37.40 | +10.75% | +10.72% | +14.76% |
| DMRA | Damora Therapeutics, Inc. | $30.62 | +4.01% | +40.33% | +800.59% |
| VIR | Vir Biotechnology, Inc. | $10.71 | +21.70% | +80.30% | +144.52% |
| INBX | Inhibrx Biosciences, Inc. | $122.72 | +48.84% | +63.54% | +390.10% |
| SNDX | Syndax Pharmaceuticals, Inc. | $19.92 | −2.92% | −6.48% | +27.20% |
| BCAX | Bicara Therapeutics Inc. | $24.58 | −11.61% | +50.06% | +117.14% |
| AAPG | Ascentage Pharma Group Internat | $16.79 | −11.12% | −36.33% | −61.38% |
| AVBP | ArriVent BioPharma, Inc. | $31.35 | +3.95% | +50.72% | +62.02% |
| REPL | Replimune Group, Inc. | $15.80 | +83.08% | +77.53% | +187.80% |
| AKTS | Aktis Oncology, Inc. | $26.69 | +10.24% | +19.15% | +19.15% |
| CGEM | Cullinan Therapeutics, Inc. | $22.95 | +31.67% | +126.78% | +200.39% |
| ORIC | ORIC Pharmaceuticals, Inc. | $13.83 | +15.06% | +69.28% | +43.76% |
| DRTS | Alpha Tau Medical Ltd. | $14.70 | +20.39% | +204.35% | +357.94% |
| IMTX | Immatics N.V. | $9.24 | +7.07% | −11.58% | +76.67% |
| GLUE | Monte Rosa Therapeutics, Inc. | $14.56 | −35.46% | −4.90% | +217.21% |
| CRVS | Corvus Pharmaceuticals, Inc. | $14.56 | +12.69% | +98.91% | +167.16% |
| JANX | Janux Therapeutics, Inc. | $18.68 | +19.97% | +36.85% | −18.82% |
| KURA | Kura Oncology, Inc. | $13.59 | +33.89% | +31.49% | +77.65% |
| CADL | Candel Therapeutics, Inc. | $13.60 | +36.55% | +150.00% | +138.18% |
| GERN | Geron Corporation | $1.55 | +4.73% | +17.42% | +9.15% |
| OLMA | Olema Pharmaceuticals, Inc. | $10.91 | −9.16% | −56.84% | +95.17% |
| ANL | Adlai Nortye Ltd. | $13.74 | +13.93% | +895.65% | +737.80% |
| RIGL | Rigel Pharmaceuticals, Inc. | $46.75 | +25.03% | +11.76% | +14.75% |
| AURA | Aura Biosciences, Inc. | $7.82 | +9.22% | +47.55% | +19.94% |
| NVCT | Nuvectis Pharma, Inc. | $25.89 | +32.50% | +204.23% | +298.92% |
| BBOT | BridgeBio Oncology Therapeutics, Inc. | $9.37 | +7.09% | −23.76% | −3.50% |
| MNPR | Monopar Therapeutics Inc. | $110.82 | +0.44% | +67.88% | +264.30% |
| CTMX | CytomX Therapeutics, Inc. | $3.37 | +3.69% | −20.71% | +68.50% |
| EIKN | Eikon Therapeutics, Inc. | $12.55 | +27.02% | −16.33% | −16.33% |
| VSTM | Verastem, Inc. | $7.08 | +16.45% | −2.07% | −21.16% |
| SGMT | Sagimet Biosciences Inc. | $10.29 | +38.12% | +71.79% | +45.34% |
| CBIO | Crescent Biopharma, Inc. | $17.00 | +0.41% | +53.43% | +15.65% |
| ARVN | Arvinas, Inc. | $9.60 | +16.79% | −16.30% | +28.34% |
| DCTH | Delcath Systems, Inc. | $16.92 | +41.71% | +70.05% | +55.37% |
| PRLD | Prelude Therapeutics Incorporated | $6.59 | +69.41% | +141.39% | +418.90% |
| CCCC | C4 Therapeutics, Inc. | $4.20 | +16.99% | +117.62% | +66.01% |
| TOI | Starling Oncology Inc | $6.20 | +19.46% | +68.94% | +78.67% |
| RLMD | Relmada Therapeutics, Inc. | $4.59 | −11.73% | +5.03% | +635.58% |
| PBYI | Puma Biotechnology, Inc. | $9.32 | +16.65% | +61.53% | +86.77% |
| CMPX | Compass Therapeutics, Inc. | $2.53 | +21.63% | −51.06% | −16.23% |
| FENC | Fennec Pharmaceuticals Inc. | $11.71 | +14.69% | +52.47% | +35.38% |
| FHTX | Foghorn Therapeutics Inc. | $6.85 | +31.73% | +31.98% | +30.48% |
| GALT | Galectin Therapeutics Inc. | $3.99 | +18.05% | −1.48% | −0.25% |
| AGEN | Agenus Inc. | $8.36 | +36.38% | +158.82% | +90.43% |
| CATX | Perspective Therapeutics, Inc. | $3.29 | +16.67% | +17.92% | −4.91% |
| ZNTL | Zentalis Pharmaceuticals, Inc. | $3.88 | −13.97% | +183.21% | +113.19% |
| STRO | Sutro Biopharma, Inc. | $21.44 | −10.70% | +95.62% | +155.24% |
| IMRX | Immuneering Corporation | $5.23 | +19.95% | −21.00% | −12.10% |
| BCYC | Bicycle Therapeutics plc | $4.39 | +11.14% | −34.28% | −38.34% |
| WHWK | Whitehawk Therapeutics, Inc. | $5.08 | +37.30% | +108.20% | +198.82% |
| ALXO | ALX Oncology Holdings Inc. | $2.00 | −0.99% | +73.91% | +81.82% |
| CGEN | Compugen Ltd. | $2.87 | +20.59% | +85.16% | +100.70% |
| MGNX | MacroGenics, Inc. Common Stock | $4.17 | +4.25% | +159.01% | +154.27% |
| GLSI | Greenwich LifeSciences, Inc. | $18.59 | +38.32% | −4.52% | +56.35% |
| PYXS | Pyxis Oncology, Inc. | $3.06 | +5.15% | +166.09% | +120.14% |
| IPHA | Innate Pharma S.A. | $2.27 | +28.10% | +24.73% | +1.34% |
| ADAG | Adagene Inc. | $3.82 | +8.22% | +107.61% | +62.55% |
| TARA | Protara Therapeutics, Inc. | $3.97 | −1.73% | −26.21% | +30.16% |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | $11.31 | +24.56% | +43.71% | +14.36% |
| NBP | NovaBridge Biosciences | $1.93 | +8.43% | −54.80% | −59.96% |
| CHRS | Coherus Oncology, Inc. | $1.37 | −6.16% | 0.00% | +17.09% |
| MENS | Jyong Biotech Ltd. | $2.23 | −8.23% | −34.60% | −95.26% |
| CUE | Cue Biopharma, Inc. | $26.76 | −17.84% | +164.69% | +9.05% |
| MOLN | Molecular Partners AG | $4.38 | +9.36% | +3.79% | +3.91% |
| KZIA | Kazia Therapeutics Limited | $13.79 | +12.94% | +175.80% | +83.87% |
| OKUR | OnKure Therapeutics, Inc. | $3.85 | −4.94% | +30.07% | +36.77% |
| ASRT | Assertio Holdings Inc | $23.50 | 0.00% | +157.11% | +98.31% |
| INDP | Indaptus Therapeutics, Inc. | $1.10 | −46.32% | −60.04% | −84.51% |
| ADCT | ADC Therapeutics SA | $1.04 | −8.77% | −70.45% | −66.34% |
| HURA | TuHURA Biosciences, Inc. | $2.04 | −7.69% | +172.00% | −30.85% |
| LIXT | Nomad Power Solutions Inc | $4.15 | −6.74% | +8.07% | +26.14% |
| BDTX | Black Diamond Therapeutics, Inc. | $2.24 | +29.48% | −10.04% | −21.95% |
| ANIX | Anixa Biosciences, Inc. | $3.66 | +5.78% | +15.82% | +22.00% |
| GNLX | Genelux Corporation | $2.72 | −7.80% | −40.22% | −27.27% |
| NTHI | NeOnc Technologies Holdings, Inc. | $4.71 | +36.92% | −46.96% | −18.72% |
| ONCY | Oncolytics Biotech Inc. | $0.86 | +7.68% | −12.10% | −12.99% |
| AMAN | Amanat Acquisition Corp | $10.69 | +5.32% | +6.79% | +6.79% |
| JATT | JATT II Acquisition Corp. | $12.46 | +11.80% | +18.62% | +18.62% |
| ACRV | Acrivon Therapeutics, Inc. | $2.18 | +39.74% | −11.38% | +63.91% |
| MAIA | MAIA Biotechnology, Inc. | $1.41 | +10.16% | −11.88% | −10.76% |
| CTOR | Citius Oncology, Inc. | $0.81 | +45.70% | −24.99% | −57.14% |
| VRCA | Verrica Pharmaceuticals Inc. | $4.94 | −7.66% | −40.48% | −17.53% |
| CRDF | Cardiff Oncology, Inc. | $1.02 | +21.43% | −61.65% | −53.85% |
| ELTX | Elicio Therapeutics, Inc. | $3.01 | +0.33% | −62.61% | −72.71% |
| APLM | Apollomics, Inc. | $26.50 | +47.22% | +37.31% | +318.64% |
| OSTX | OS Therapies Incorporated | $1.65 | +7.84% | +23.13% | −24.66% |
| PLRX | Pliant Therapeutics, Inc. | $1.14 | +5.56% | −8.80% | −23.49% |
| XBIT | XBiotech Inc. | $2.30 | +1.77% | −3.36% | −28.13% |
| PMVP | PMV Pharmaceuticals, Inc. | $1.31 | +10.59% | +6.10% | −8.10% |
| BOLD | Boundless Bio, Inc. | $2.94 | +18.55% | +140.98% | +160.18% |
| RNXT | RenovoRx, Inc. | $1.42 | +47.15% | +70.06% | +58.13% |
| HRTX | Heron Therapeutics, Inc. | $0.32 | −29.76% | −74.36% | −76.59% |
| XLO | Xilio Therapeutics, Inc. | $9.08 | −0.11% | −3.49% | −7.35% |
| IMMP | Immutep Limited | $0.38 | +0.50% | −87.05% | −77.54% |
| TIL | Instil Bio, Inc. | $7.81 | +9.23% | −30.70% | −69.62% |
| IBO | Impact BioMedical Inc. | $0.46 | +6.53% | −11.33% | −20.79% |
| BKHA | Black Hawk Acquisition Corporation | $11.89 | −1.74% | +5.69% | +8.09% |
| HOWL | Werewolf Therapeutics, Inc. | $0.89 | +96.47% | +37.98% | −35.04% |
| KPTI | Karyopharm Therapeutics Inc. Common Stock | $1.92 | −72.92% | −73.30% | −69.57% |
| CNTX | Context Therapeutics Inc. | $0.44 | −30.00% | −71.91% | −50.13% |
| ATNM | Actinium Pharmaceuticals, Inc. | $1.08 | +26.46% | −21.17% | −39.66% |
| BCTX | BriaCell Therapeutics Corp. | $3.77 | +6.20% | −47.42% | −49.67% |
| KYNB | Kyntra Bio, Inc. | $8.10 | +14.89% | −11.57% | −23.80% |
| BYSI | BeyondSpring Inc. | $0.72 | −38.44% | −55.27% | −60.43% |
| EVAX | Evaxion A/S | $3.35 | +15.92% | −28.87% | +4.49% |
| LTRN | Lantern Pharma Inc. | $2.18 | −21.86% | −29.90% | −52.30% |
| NXTC | NextCure, Inc. | $5.91 | +15.43% | −55.50% | +13.33% |
| PSTV | Plus Therapeutics Inc | $3.84 | +2.90% | −72.59% | −68.67% |
| ATOS | Atossa Therapeutics, Inc. | $2.68 | +13.56% | −71.64% | −76.49% |
| CVM | CEL-SCI Corporation | $1.48 | +25.42% | −71.26% | −85.98% |
| MRKR | Marker Therapeutics, Inc. | $1.52 | +24.59% | −1.30% | +20.63% |
| CLRB | Cellectar Biosciences, Inc. | $2.54 | +4.96% | −26.80% | −45.96% |
| BFRI | Biofrontera Inc. | $1.51 | +43.81% | +108.28% | +63.77% |
| CCM | Concord Medical Services Holdings Limited | $4.95 | +9.76% | +15.93% | −10.65% |
| ABVC | ABVC BioPharma, Inc. | $0.80 | −21.58% | −63.47% | −72.70% |
| ALLR | Allarity Therapeutics, Inc. | $1.33 | +8.13% | +16.67% | +41.34% |
| RADX | Radiopharm Theranostics Limited | $2.48 | −32.24% | −51.94% | −55.71% |
| TPST | Tempest Therapeutics, Inc. | $1.11 | +18.72% | −62.37% | −89.50% |
| CTXR | Citius Pharmaceuticals, Inc. | $0.60 | +16.77% | −28.81% | −52.09% |
| MDCX | Medicus Pharma Ltd. | $0.26 | −17.92% | −83.69% | −87.97% |
| INTS | Intensity Therapeutics, Inc. | $4.90 | +7.11% | −51.89% | −37.24% |
| LSTA | Lisata Therapeutics, Inc. | $1.74 | +20.83% | −11.22% | −31.23% |
| AKTX | Akari Therapeutics, Plc | $7.87 | −6.97% | −32.16% | −77.77% |
| PHIO | Phio Pharmaceuticals Corp. | $1.17 | +11.43% | +7.34% | −41.21% |
| GTBP | GT Biopharma, Inc. | $0.30 | −10.27% | −63.32% | −72.50% |
| BLRX | BioLineRx Ltd. | $2.85 | +1.06% | +1.79% | −25.97% |
| PDSB | PDS Biotechnology Corporation | $0.22 | −68.04% | −73.41% | −82.96% |
| MBRX | Moleculin Biotech, Inc. | $0.61 | −72.10% | −83.12% | −95.75% |
| TOVX | Theriva Biologics, Inc. | $0.24 | +11.95% | −9.58% | −45.33% |
| APRE | Aprea Therapeutics, Inc. | $0.95 | +51.98% | +11.36% | −40.63% |
| LNAI | Lunai Bioworks Inc. | $2.20 | −1.35% | −71.71% | −87.99% |
| XBIO | Xenetic Biosciences, Inc. | $3.82 | +52.80% | +77.67% | +33.57% |
| IMNN | Imunon, Inc. | $1.66 | +8.50% | −57.97% | −73.86% |
| CNSP | CNS Pharmaceuticals, Inc. | $5.80 | +14.40% | +9.43% | −11.31% |
| AIM | AIM ImmunoTech Inc. | $0.25 | +1.60% | −77.99% | −89.97% |
| CURX | Curanex Pharmaceuticals Inc | $4.75 | +2495.63% | +1190.76% | +18.16% |
| BOLT | Bolt Biotherapeutics, Inc. | $3.85 | −3.12% | −33.51% | −29.28% |
| CANF | Can-Fite BioPharma Ltd. | $3.32 | +5.40% | −24.55% | −74.46% |
| ITOC | iTonic Holdings Ltd. | $0.27 | +9.68% | −37.07% | −51.75% |
| LIMN | Liminatus Pharma, Inc. | $4.61 | +4375.73% | +619.19% | +35.59% |
| NCNA | NuCana plc | $1.47 | +16.67% | −59.62% | −56.76% |
| PCSA | Processa Pharmaceuticals, Inc. | $2.18 | −15.83% | −25.60% | −60.36% |
| KAPA | Kairos Pharma, Ltd. | $0.25 | −19.94% | −65.95% | −79.82% |
| BCAB | BioAtla, Inc. | $3.26 | −4.12% | −87.79% | −81.69% |
| HCWB | HCW Biologics Inc. | $2.60 | −1.89% | +132.14% | −53.15% |
| APVO | Aptevo Therapeutics Inc. | $2.46 | −41.57% | −73.80% | −92.81% |
| OSRH | OSR Health, Inc. | $0.12 | −73.09% | −80.22% | −88.47% |
| CRIS | Curis, Inc. | $1.59 | −66.10% | +62.24% | −3.64% |
| RDHL | RedHill Biopharma Ltd. | $0.61 | −13.56% | −41.25% | −55.83% |
| CLDI | Calidi Biotherapeutics, Inc. | $1.31 | −25.57% | +11.02% | −16.03% |
| GOVX | GeoVax Labs, Inc. | $0.64 | −15.54% | −87.60% | −96.61% |
| ARTL | Artelo Biosciences, Inc. | $0.72 | −28.99% | −81.18% | −97.47% |
| NXTS | Nexentis Technologies Inc. | $1.85 | +10.78% | −83.38% | −96.64% |
| PPBT | Purple Biotech Ltd | $1.65 | +14.58% | −75.00% | −92.53% |
| RNAZ | TransCode Therapeutics, Inc. | $2.53 | −53.58% | −65.81% | −74.16% |
| PPCB | Propanc Biopharma, Inc. | $1.13 | −14.39% | −92.09% | −98.66% |
| SLXN | Silexion Therapeutics Corp | $0.37 | −85.57% | −80.59% | −94.88% |
| DCOY | Decoy Therapeutics Inc. | $2.98 | −20.32% | −61.91% | −95.58% |
| BDRX | Biodexa Pharmaceuticals Plc | $1.18 | −24.84% | −90.41% | −96.20% |
| APM | Aptorum Group Ltd | $8.41 | −6.45% | +685.98% | +260.94% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.